Dana Farber Cancer Institute, Brigham and Women's Hospital — Boston, Massachusetts

Dana Farber Cancer Institute, Brigham and Women's Hospital is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute, Brigham and Women's Hospital has participated in 1 clinical trials.

Therapeutic areas: Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma.

Sponsors: Orbus Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute, Brigham and Women's Hospital?

Dana Farber Cancer Institute, Brigham and Women's Hospital has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute, Brigham and Women's Hospital conducted?

Dana Farber Cancer Institute, Brigham and Women's Hospital has 1 clinical trials on record. Their work covers Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma.

Is Dana Farber Cancer Institute, Brigham and Women's Hospital accredited by Crixeo Health?

Dana Farber Cancer Institute, Brigham and Women's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute, Brigham and Women's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.